Name | Value |
---|---|
MEASURE TITLE | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
CMS ID | CMS135v3 |
VERSION NUMBER | 3 |
DEVELOPER | American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI) |
STEWARD | American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI) |
COPYRIGHT | Copyright 2013 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved. |
VALUE SETS |
|
GUID | 430ffc53-4122-4421-88cc-2edd8117bb3c |
NQF NUMBER | 0081 |
DESCRIPTION | Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge |
CATEGORY | Individual Characteristic |
IDENTIFIER | 135 |
STATUS | Complete |
TYPE | PROCESS |
MEASURE SET | CY 2014 EP |